ADVANCED GASTRIC CANCER
Clinical trials for ADVANCED GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could cutting one amino acid boost stomach cancer treatment?
Disease control Recruiting nowThis study tests whether a diet low in leucine (an amino acid) is safe and helps standard chemotherapy and immunotherapy work better for people with advanced stomach cancer. About 73 adults aged 18-70 with metastatic disease will follow this special diet alongside their treatment…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New combo therapy aims to boost stomach cancer treatment
Disease control Recruiting nowThis study tests whether adding extra drugs to standard chemo and immunotherapy can help people with advanced stomach cancer. About 78 adults with stage III or IV stomach cancer will receive SHR1701 plus chemotherapy, along with either an EZH2 inhibitor or an anti-angiogenic drug…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New hope for advanced stomach cancer: personalized vaccine and cell therapy trial launches
Disease control Recruiting nowThis early-stage trial tests a new treatment for adults with advanced gastric cancer that has not responded to standard therapies. The treatment combines a personalized vaccine (made from the patient's tumor mutations) with immune cells trained to attack the cancer. The main goal…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE1 • Sponsor: Jia Wei • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug cocktail targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis study tests a combination of two drugs—disitamab vedotin and tucatinib—for people with advanced breast or stomach cancers that have a protein called HER2. The goal is to see if the combo is safe and can shrink or control tumors. About 172 adults with these cancers who have a…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New pill targets common cancer driver in advanced tumors
Disease control Recruiting nowThis early-phase study tests a new experimental drug called BGB-53038 in people with advanced or metastatic solid tumors that have a specific genetic change (KRAS mutation or amplification). The drug is a pan-KRAS inhibitor, meaning it aims to block many forms of the faulty KRAS …
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Promising new combo tackles advanced stomach cancer in early trial
Disease control Recruiting nowThis study tests a new drug combination (iparomlimab and tuvonralimab, called QL1706) plus chemotherapy in people with advanced stomach or gastroesophageal junction cancer that hasn't been treated yet. The goal is to see if the combination shrinks tumors and is safe. About 32 par…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New hope for stomach cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called SHR2554 combined with other cancer treatments for people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery or has spread. The goal is to see if the combination is safe and helps shrink tumors. About 351 …
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New study: app and nurse calls ease chemo side effects for cancer patients
Symptom relief Recruiting nowThis study tests whether a digital health platform, which includes a symptom-tracking app and a nurse-led phone program, can help cancer patients better manage chemotherapy side effects. About 414 adults with early or advanced stomach, lung, breast, or colon cancer will participa…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Scientists hunt for clues to cancer drug resistance in 400 patients
Knowledge-focused Recruiting nowThis study enrolls 400 adults with advanced breast, lung, stomach, or bladder cancer who are receiving antibody-drug conjugates (ADCs), a type of targeted therapy. Researchers will compare tumor samples taken before treatment and after the cancer progresses to identify genetic or…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC